Evidence map›Paper›PMID 37322178›Full record

ArticleNature immunology2023

SALL1 enforces microglia-specific DNA binding and function of SMADs to establish microglia identity.

Bethany R Fixsen, Claudia Z Han, Yi Zhou, Nathanael J Spann, Payam Saisan, Zeyang Shen, Christopher Balak, Mashito Sakai, Isidoro Cobo, Inge R Holtman and 12 more

Open access · hybridAbstract read
In one paragraph

Article in Nature immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
10.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Microglial fructose metabolism is essential for glioblastoma growth.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 4 institutions in 4 countries.

Bethany R FixsenDepartment of Cellular and Molecular Medicine, School of Medicine, UC San Diego, La Jolla, CA, USA.
Claudia Z HanDepartment of Cellular and Molecular Medicine, School of Medicine, UC San Diego, La Jolla, CA, USA.
Yi ZhouDepartment of Cellular and Molecular Medicine, School of Medicine, UC San Diego, La Jolla, CA, USA.
Nathanael J SpannDepartment of Cellular and Molecular Medicine, School of Medicine, UC San Diego, La Jolla, CA, USA.
Payam SaisanDepartment of Cellular and Molecular Medicine, School of Medicine, UC San Diego, La Jolla, CA, USA.
Zeyang ShenDepartment of Cellular and Molecular Medicine, School of Medicine, UC San Diego, La Jolla, CA, USA.
Christopher BalakDepartment of Cellular and Molecular Medicine, School of Medicine, UC San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0000-0001-9149-5982
Mashito SakaiDepartment of Cellular and Molecular Medicine, School of Medicine, UC San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-4908-2727
Isidoro CoboDepartment of Cellular and Molecular Medicine, School of Medicine, UC San Diego, La Jolla, CA, USA.
Inge R HoltmanDepartment of Cellular and Molecular Medicine, School of Medicine, UC San Diego, La Jolla, CA, USA.
Anna S WardenDepartment of Cellular and Molecular Medicine, School of Medicine, UC San Diego, La Jolla, CA, USA.
Gabriela RamirezSanford Consortium for Regenerative Medicine, La Jolla, CA, USA.
Jana G CollierDepartment of Cellular and Molecular Medicine, School of Medicine, UC San Diego, La Jolla, CA, USA.
Martina P PasillasDepartment of Cellular and Molecular Medicine, School of Medicine, UC San Diego, La Jolla, CA, USA.
Miao YuDepartment of Cellular and Molecular Medicine, School of Medicine, UC San Diego, La Jolla, CA, USA.
Rong HuDepartment of Cellular and Molecular Medicine, School of Medicine, UC San Diego, La Jolla, CA, USA.
Bin LiDepartment of Cellular and Molecular Medicine, School of Medicine, UC San Diego, La Jolla, CA, USA.
Sarah BelhocineAxe Neuroscience, Centre de Recherche du CHU de Québec, Université Laval, Quebec, Quebec, Canada.
David GosselinAxe Neuroscience, Centre de Recherche du CHU de Québec, Université Laval, Quebec, Quebec, Canada.ORCID http://orcid.org/0000-0001-5327-2868
Nicole G CoufalSanford Consortium for Regenerative Medicine, La Jolla, CA, USA.ORCID http://orcid.org/0000-0001-6547-1733
Bing RenDepartment of Cellular and Molecular Medicine, School of Medicine, UC San Diego, La Jolla, CA, USA.
Christopher K GlassDepartment of Cellular and Molecular Medicine, School of Medicine, UC San Diego, La Jolla, CA, USA. ckg@ucsd.edu.ORCID http://orcid.org/0000-0003-4344-3592
University of California San Diego · USCentre hospitalier de l'Université Laval · CASanford Consortium for Regenerative Medicine · USUniversity Medical Center Groningen · NL

Funding

UCSD Shiley-Marcos Alzheimer's Disease Research Center P30P30AG062429 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Tamar Gollan · 2019 to 2026
$34.9M
Mechanisms controlling human microglia gene expressionR01NS096170 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GLASS, CHRISTOPHER K · 2016 to 2025
$4.3M
The Contribution of Microglial MEF2C to Brain DevelopmentR01NS124637 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Nicole Gabriele Coufal · 2022 to 2026
$2.0M
Notice of Special Interest: Administrative Supplements to Promote Research Continuity and Retention of NIH Mentored Career Development (K) Award Recipients and ScholarsK08NS109200 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI COUFAL, NICOLE GABRIELE · 2018 to 2022
$1.1M
Illumina NovaSeq 6000 Sequencing SystemS10OD026929 · OD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JEPSEN, KRISTEN LYNN · 2019 to 2019
$600k
Gene regulatory networks influencing neuron-microglia interactions in fetal brain development.K99MH129983 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HAN, CLAUDIA Z · 2022 to 2023
$230k
Decoding Alzheimer's disease-related enhancers in microgliaF30AG062159 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIXSEN, BETHANY ROSE · 2018 to 2021
$162k
NIA NIH HHS F30 AG062159NIA NIH HHS P30 AG062429NIH HHS S10 OD026929NIMH NIH HHS K99 MH129983NINDS NIH HHS K08 NS109200NINDS NIH HHS R01 NS096170NINDS NIH HHS R01 NS124637
6 · The paper itself

Abstract

Spalt-like transcription factor 1 (SALL1) is a critical regulator of organogenesis and microglia identity. Here we demonstrate that disruption of a conserved microglia-specific super-enhancer interacting with the Sall1 promoter results in complete and specific loss of Sall1 expression in microglia. By determining the genomic binding sites of SALL1 and leveraging Sall1 enhancer knockout mice, we provide evidence for functional interactions between SALL1 and SMAD4 required for microglia-specific gene expression. SMAD4 binds directly to the Sall1 super-enhancer and is required for Sall1 expression, consistent with an evolutionarily conserved requirement of the TGFβ and SMAD homologs Dpp and Mad for cell-specific expression of Spalt in the Drosophila wing. Unexpectedly, SALL1 in turn promotes binding and function of SMAD4 at microglia-specific enhancers while simultaneously suppressing binding of SMAD4 to enhancers of genes that become inappropriately activated in enhancer knockout microglia, thereby enforcing microglia-specific functions of the TGFβ-SMAD signaling axis.

Indexed as

MicrogliaTranscription FactorsAnimalsBinding SitesDNAMiceMice, KnockoutPromoter Regions, GeneticTransforming Growth Factor betaDNASall1 protein, mouseTranscription FactorsTransforming Growth Factor beta

Identifiers

PMID37322178
PMCPMC10307637
OpenAlexW4380871083

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.